Search results for Quilizumab
Quilizumab Biosimilar – Anti-IGHE mAb – Research Grade, ProteoGenix, PX-TA1283
Description of Quilizumab Biosimilar - Anti-IGHE mAb - Research Grade General information on Anti-IGHE[Homo sapiens] (Quilizumab) Monoclonal Antibody Quilizumab has been investigated for the treatment of Allergic Rhinitis.
Host
Reactivity
Applications
Conjugation
Quilizumab, Abbexa, abx831240
Quilizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IGHE, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Quilizumab Biosimilar - Research Grade, ichor.bio, ICH5796
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Quilizumab (HV064046), abinScience, HV064046
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.